ARCHIVES

Charles Blanke Named Chair-Elect of SWOG

This article is from The Cancer Letter archive.

Vol. 38 No. 16 | April 20, 2012

Download PDF Visit The Full Archive

Related Articles

NCI CTEP: Approved Trials For The Month of October

October 28, 2011

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997

News Organizations Protest invitation-Only Press Conferences, Exclusion of Reporters

May 20, 1994

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983